Luca Santarelli’s PhIII is good to go, he has a new app to stop Covid-19 from infecting the data and $110M to pave the way
Luca Santarelli barely skipped a beat when he sold Therachon to Pfizer last year in an $810 million deal. The pharma giant wanted the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
